Key facts
- Notable investors include Foresite Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Propeller Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Propeller Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Propeller Bio
Developer of a biotech company intended to discover and develop innovative biologic therapeutics targeting multiple disease-driving pathways. The company offers expertise in creating therapies with synergistic effects, extensive drug discovery and development experience, and a focus on patient safety, enabling patients with unmet medical needs to access more effective treatments.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2025
- Employees
- 25
- Website
- propeller.bio/
- Ownership
- Privately Held (backing)
Propeller Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Propeller Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Propeller Bio in its N-PORT filings yet. We sweep new filings monthly.